How spaceflight challenges human cardiovascular health.
Postflight orthostatic intolerance
Spaceflight Associated Neuroocular syndrome
cardiac atrophy
cardiovascular remodelling
commercial spaceflight
countermeasure
microgravity
neck vein thrombosis
Journal
European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430
Informations de publication
Date de publication:
05 08 2022
05 08 2022
Historique:
received:
12
10
2021
revised:
08
01
2022
accepted:
06
02
2022
pubmed:
12
2
2022
medline:
10
8
2022
entrez:
11
2
2022
Statut:
ppublish
Résumé
The harsh environmental conditions in space, particularly weightlessness and radiation exposure, can negatively affect cardiovascular function and structure. In the future, preventive cardiology will be crucial in enabling safe space travel. Indeed, future space missions destined to the Moon and from there to Mars will create new challenges to cardiovascular health while limiting medical management. Moreover, commercial spaceflight evolves rapidly such that older persons with cardiovascular risk factors will be exposed to space conditions. This review provides an overview on studies conducted in space and terrestrial models, particularly head-down bedrest studies. These studies showed that weightlessness elicits a fluid shift towards the head, which likely predisposes to the spaceflight-associated neuro-ocular syndrome, neck vein thrombosis, and orthostatic intolerance after return to Earth. Moreover, cardiovascular unloading produces cardiopulmonary deconditioning, which may be associated with cardiac atrophy. In addition to limiting physical performance, the mechanism further worsens orthostatic tolerance after return to Earth. Finally, space conditions may directly affect vascular health; however, the clinical relevance of these findings in terms of morbidity and mortality is unknown. Targeted preventive measures, which are referred to as countermeasures in aerospace medicine, and technologies to identify vascular risks early on will be required to maintain cardiovascular performance and health during future space missions.
Identifiants
pubmed: 35148376
pii: 6527203
doi: 10.1093/eurjpc/zwac029
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1399-1411Commentaires et corrections
Type : CommentIn
Informations de copyright
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2022. For permissions, please email: journals.permissions@oup.com.
Déclaration de conflit d'intérêts
Conflict of interest: J.J. has served as a consultant for Novartis, Boehringer-Ingelheim, and Novo-Nordisk and is cofounder of Eternygen GmbH. The other authors declare that they have no conflict of interest.